• 消费提醒:购买二手车 留意隐形瑕疵 2019-07-20
  • 【砥砺奋进六十年·全国主流媒体宁夏行】非遗文化技艺助农民脱贫 2019-06-26
  • 叶倾城的专栏作者中国国家地理网 2019-06-26
  • 图解:喜迎十九大,听这19位名家的文艺“初心” 2019-06-20
  • 辣评 张学之:那些年厨卫展上的老人新面孔 2019-06-20
  • 这个五月不一般 《复仇者联盟3》领衔大片季 2019-06-19
  • 乌拉圭主帅“袒护”苏亚雷斯:有时球门好像变窄了 2019-06-19
  • 回复@遇得:难道你认为他们没有深入领会 2019-06-18
  • 夏季肠道容易“中风” 2019-06-18
  • 骗子用女子照片制作“通缉令” 诈骗对方11万 2019-06-01
  • 中央纪委:生态环境部纪检组举报方式公布 2019-05-21
  • 住房和城乡建设部部长王蒙徽:房价过快上涨势头得到有效抑制 2019-05-21
  • 滴滴,你的“美好出行”承诺何时能兑现 2019-05-21
  • 陈秋冬:评估AI项目 我们需要思考三个问题 2019-05-19
  • 马刺头号球星申请换队并确定下家 波波维奇也不好使了 2019-05-14
  • 英语资讯
    News

    360重庆时时彩走势图表:国际英语新闻:Spotlight: U.S.-China biotech cooperation benefits patients, investors in both countries

    Source: Xinhuanet    2019-04-11  我要投稿   论坛   Favorite  

    时时彩计划群太阳 www.waep.com.cn NEW YORK, April 10 (Xinhua) -- U.S.-China partnership in the biotech sector is promising and will benefit both patients and investors in the two countries, said U.S. biotech firms and investors.

    "There are many very smart scientists (in China), and they are very entrepreneurial ... We think China is a big opportunity for our (biotech drug) products," RJ Tesi, chief executive officer and chief medical officer of San Diego-based immunology company INmune Bio, told Xinhua in an interview on Tuesday after ringing the Nasdaq Stock Market closing bell here.

    INmune Bio recognized very early that there were investors and capital in China, and it wanted to diversify its capital base beyond North America, so it selected Univest Securities, a U.S.-based financial service provider founded primarily by Chinese-Americans, as the lead underwriter, in a bid to help it connect with Chinese investors and Chinese market, explained Tesi.

    He noted that "it's a strategy that has paid off well."

    "We think it's a good investment opportunity to act as lead placement agent of INmune Bio, so we decided to help them get listed in Nasdaq and conduct the initial public offering," said Guo Yi, chief operation officer of Univest Securities, citing the "high quality of INmune Bio's immunotherapies."

    Univest Securities took INmune Bio to 13 Chinese cities, including Beijing, Shanghai, Shenzhen, and Hong Kong, for road-show, helped it arrange business meetings with Chinese capital investment companies, and discussed collaborative opportunities with China's State Food and Drug Administration (SFDA), according to Guo.

    Chinese medical establishments and investors are eagerly searching for quality biotech programs in the United States. The Chinese medical institutes will cooperate with U.S. biotech companies to license in their technologies, initiate clinical trials upon the approval of SFDA, and ultimately sell the legal drugs. Such cooperation has been normal in the Chinese market, Guo said.

    "About 30 percent investors of INmune Bio are from the Chinese mainland," Guo said, adding that "Univest Securities has a dream to bring quality U.S. technologies to China and benefit the Chinese people."

    Share price of INmune Bio surged 1.84 dollars, or 21.40 percent, on Tuesday to close at 10.44 U.S. dollars per share.

    "I think the fact that the share price is beginning to move is a reflection that people have begun to understand all our programs, understand what we're trying to do, and hopefully reflects the fact that they think we have great prospects," Tesi said with excitement.

    "If you make patients better, investors do well. And those are two customers, investors and patients... They're equally important," he added.

    INmune Bio went public in Nasdaq Stock Market on Feb. 4 with public offering price at 8 dollars per share. The company aimed to raise up to 20 million dollars to fund its research and drug development activities.

    It is a clinical-stage biotechnology company that focuses on reprogramming the innate immune system to fight diseases, such as cancer, neurodegenerative disease, malignancy and Alzheimer's disease.


    将本页收藏到:
    上一篇:国际英语新闻:EU27 grants flexible Brexit extension until end of October
    下一篇:国际英语新闻:Chinese cultural event kicks off in NE Egypt

    最新更新
    论坛精彩内容
    网站地图 - 学习交流 - 恒星英语论坛 - 时时彩计划群太阳 - 时时彩计划群太阳 - 时时彩计划群太阳 - 时时彩计划群太阳
    Copyright ©2006-2007 时时彩计划群太阳 www.waep.com.cn All Rights Reserved
  • 消费提醒:购买二手车 留意隐形瑕疵 2019-07-20
  • 【砥砺奋进六十年·全国主流媒体宁夏行】非遗文化技艺助农民脱贫 2019-06-26
  • 叶倾城的专栏作者中国国家地理网 2019-06-26
  • 图解:喜迎十九大,听这19位名家的文艺“初心” 2019-06-20
  • 辣评 张学之:那些年厨卫展上的老人新面孔 2019-06-20
  • 这个五月不一般 《复仇者联盟3》领衔大片季 2019-06-19
  • 乌拉圭主帅“袒护”苏亚雷斯:有时球门好像变窄了 2019-06-19
  • 回复@遇得:难道你认为他们没有深入领会 2019-06-18
  • 夏季肠道容易“中风” 2019-06-18
  • 骗子用女子照片制作“通缉令” 诈骗对方11万 2019-06-01
  • 中央纪委:生态环境部纪检组举报方式公布 2019-05-21
  • 住房和城乡建设部部长王蒙徽:房价过快上涨势头得到有效抑制 2019-05-21
  • 滴滴,你的“美好出行”承诺何时能兑现 2019-05-21
  • 陈秋冬:评估AI项目 我们需要思考三个问题 2019-05-19
  • 马刺头号球星申请换队并确定下家 波波维奇也不好使了 2019-05-14
  • 飞艇pk10一天稳赚5000北京 七码滚雪球多少期一收 幸运飞艇计划软件苹果免费版 凤凰彩票官方app 超神冠军单双计划 中国最正规pk10app彩票 官方pk10app pk10追345678窍门 双色球2018全年 山东十一选五推荐 广东11选5技巧稳赚公式 幸运28怎么压才能稳赚 飞艇计划软件精准在线 红马计划软件app 11选5必出四码三组 双色球机选复式号码投注